From July 1, 2022 to September 30, 2022, the company has repurchased 169,090 shares, representing 0.82% for KRW 2,231.28 million. With this, the company has completed the repurchase of 380,360 shares, representing 1.86% for KRW 4,984.4 million under the buyback announced on May 17, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24,300 KRW | -0.21% |
|
+2.32% | +17.96% |
2023 | Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2022 | Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022. | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.96% | 423M | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
+10.74% | 25.92B | |
-13.50% | 26.03B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B | |
-12.61% | 10.64B |
- Stock Market
- Equities
- A228760 Stock
- News Genomictree Inc.
- Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022.